Clinical and Translational Science Institute at URochester Medicine

Disability as Difference: Reducing Researcher Roadblocks | July 9

This presentation will highlight Disability as Difference/Reducing Researcher Roadblocks' (D2/R3) alignment with translational science principles, i.e., generalizable solutions in the context of disability as a disease-universal barrier and prioritization of unmet needs.

Karen Bonuck, PhD, of the Einstein College of Medicine, will present the project's mixed-methods findings, currently in a clinical trial. She will also describe a collaborative grant proposal with URochester Medicine that builds on D2/R3's researcher-focused approach to address barriers across the broader research ecosystem.

Thursday, July 9, noon to 1 p.m. Virtual Event.

https://events.rochester.edu/event/disability-as-difference-reducing-researcher-roadblocks-d2r3

Disability as Difference: Reducing Researcher Roadblocks This presentation will highlight Difference/Reducing Researcher Roadblocks' (D2/R3) alignment with translational science principles, i.e., generalizable solutions (disability as a disease-universal barrier) and prioritization of unmet needs (NIH designated people with disabilities a health dispariti...

📚 The Translational Science Scholar Award Program is supporting two new, innovative translational science projects: an automated diagnostic system for rapidly evaluating palpable breast lumps and a digital storytelling intervention for cancer patients and their caregivers to better equip them to make healthcare decisions.

These projects are led by Thomas Marini and Rachel Rodenbach, our newest Translational Science Scholars.

↪️ Read more: https://www.urmc.rochester.edu/clinical-translational-science-institute/stories/june-2026/translational-science-scholars-to-develop-automated-diagnosis-of-breast-lumps-and-digital-storytelli

THURSDAY: Using Novel Machine Learning Methods to Improve Outcomes in Premature Newborns

In this Translational Science Grand Rounds presentation, Andrew Dylag, MD, FAAP, associate professor of Pediatrics, will describe the use of novel machine learning methods—in partnership with CTSI data infrastructure—in improving outcomes for extremely premature newborns.

Join us for this virtual event on Thursday, June 11 from noon to 1 p.m.

https://events.rochester.edu/event/time-series-machine-learning-to-model-longitudinal-outcomes-in-extremely-premature-infants

Time-Series Machine Learning to Model Longitudinal Outcomes in Extremely Premature Infants Extremely premature newborns are hospitalized for months from birth to discharge, generating rich and deep longitudinal time-series data. This presentation covers the use of novel machine learning methods, in partnership with the CTSI data infrastructure, to improve outcome predictions for this vuln...

Using Novel Machine Learning Methods to Improve Outcomes in Premature Newborns | June 11

In this Translational Science Grand Rounds presentation, Andrew Dylag, MD, FAAP, associate professor of Pediatrics, will describe the use of novel machine learning methods—in partnership with CTSI data infrastructure—in improving outcomes for extremely premature newborns.

Join us for this virtual event on Thursday, June 11 from noon to 1 p.m.

https://events.rochester.edu/event/time-series-machine-learning-to-model-longitudinal-outcomes-in-extremely-premature-infants

Time-Series Machine Learning to Model Longitudinal Outcomes in Extremely Premature Infants Extremely premature newborns are hospitalized for months from birth to discharge, generating rich and deep longitudinal time-series data. This presentation covers the use of novel machine learning methods, in partnership with the CTSI data infrastructure, to improve outcome predictions for this vuln...

Today is Clinical Trials Day—an opportunity to recognize and appreciate the clinical research workers and study participants who advance medicine for the benefit of all.

Our own Clinical Research Center (CRC) supports research teams across the University with top-tier study subject care and expertise provided by the invaluable nursing staff.

Learn more about how the CRC's revitalized facility at the Health Sciences Campus is serving the community and advancing medical discoveries:

https://www.urmc.rochester.edu/news/story/after-major-flood-urmc-reopens-larger-more-modern-clinical-research-center

After Major Flood, University of Rochester Medicine Reopens Larger, More Modern Clinical Research Center University of Rochester Medicine has reopened its renovated Clinical Research Center, restoring and enhancing a critical resource for clinical studies across the institution.

NEXT WEEK:

On June 1, discover how Texas A&M and Phillips North leveraged the MyCap Mobile App in the Persistent Readiness Through Early Prediction (PREP) study. To assess vaccine-mediated immune responses in healthy adults after receiving the Typhim Vi and PPSV23 vaccines, 210 individuals were tasked with completing daily questionnaires via MyCap, uploading facial photographs, and recording scripted audio clips for staff review in this study.

Following the study team’s presentation of their use case, the MyCap team will also share updates on new app features, app growth milestones, and insights into other published use cases.

Register Now: https://events.rochester.edu/event/mycap-in-action-use-of-mycap-in-the-prep-study

MyCap in Action: Use of MyCap in the PREP Study MyCap in Action: Use of MyCap in the PREP Study and Additional Use Cases Discover how Texas A&M and Phillips North leveraged the MyCap Mobile App in the Persistent Readiness Through Early Prediction (PREP) study. To assess vaccine-mediated immune responses in healthy adults after receiving the Typhi...

Congratulations to our latest class of Clinical and Translational Sciences majors! Professor Edwin van Wijngaarden was on-hand for commencement for these young scholars last week. We can't wait to see them make an impact in the field of clinical and translational science and research.

CTSI Support for Multi-Site Studies in Clinical Research - June 16

Advancing Clinical and Translational Ideas into Vetted Grant Applications for Targeted Extramural Funding Opportunities (ACTIVATE) represents CTSI's s support framework for developing grants for multi-site clinical trials.

ACTIVATE provides investigators with early-stage consultations on clinical and data coordination, team assembly, multi-site budgeting, alignment with funding opportunities, and more. This event will provide a comprehensive overview of resources you should consider when developing a proposal.

Learn more and register: https://events.rochester.edu/event/ur-ctsi-support-for-multi-site-studies-in-clinical-research-activate

UR CTSI Support for Multi-Site Studies in Clinical Research: ACTIVATE UR CTSI Support for MUlti-Site Studies in CLinical Research (UR CTSI MUSSCL) PART 1: ACTIVATE Advancing Clinical and Translational Ideas into Vetted Grant Applications for Targeted Extramural Funding Opportunities (ACTIVATE) represents the University of Rochester Clinical and Translational Science I...

University of Rochester Medicine connects patient care with innovation to advance healthcare. That work begins with health research and clinical trials that are accessible to all.

CTSI is proud to support the new Health Research website, which serves as a public-facing hub to link community members with information on research studies.

Learn more about this new resource:

https://www.urmc.rochester.edu/clinical-translational-science-institute/stories/may-2026/health-research-and-clinical-trials-website-connects-you-to-research